SK bioscience\'s first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025,with interim results expected by 2026.

Key Highlights: GHG emissions intensity reduced by 2.33% to 10.04 tonnes of CO2e per tonne of aluminium produced

DUBAI,UAE,Dec. 14,2024-- The panel at Telecom Review Leaders\' Summit 18th edition,titled \'World First 5G-A Region Sets Sail,\' began with an opening speech by Toni Eid,Founder of Telecom Review Grou

SHANGHAI,Dec. 16,2024--The Cambridge Generative AI in Education Conference 2024 recently concluded in Cambridge,UK. The event was co-organized by the Faculty of Education at the University of Cambridg

The Brand\'s Fifth Asia Pacific Property will be an Urban Sanctuary in the Heart of the City BANGKOK,Dec. 16,2024--The Standard,Singaporehas officially opened its doors on December 15,2024. The proper

SAN FRANCISCO andSUZHOU,China,Dec. 16,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qua

BEIJING,Dec. 16,2024-- Sounding the horns,a China-Europe freight train loaded with electronic goods,light industrial items and more drew away from a train station in Southwest China\'sChongqing in ear

KOTA KINABALU,Malaysia,Dec. 16,2024-- A groundbreaking new book by Professor Dr. Mike Chan,"STEM CELLS,PEPTIDES & IMMUNOTHERAPY: Handbook on Regenerative Medicine for Animals," introduc

The CEO presentation from Minesto\'s Capital Market Day is now available on the company\'s website and YouTube channel. The Capital Market Day was held on 11 December 2024 at the company\'s workshop i

Exclusive Market Insights Recorded Daily from the NYSE Trading Floor NEW YORK,Dec. 16,2024-- The New York Stock Exchange (NYSE) is proud to offer a new daily pre-market update and additional content